Table 3 Details of plasma exchange therapy
Patient | BMI (kg/m2) | Time ICU admission to TPE (days) | No. of TPE procedures (day of application) | Plasma volume (ml) | Total Volume exchange per PV | Anti-coagulation | Membrane/Centrifuge |
|---|---|---|---|---|---|---|---|
1 | 24.9 | 0 | 2 (1,2) | 3.70 | 1.6 | Heparin | M |
2 | 22.4 | 1 | 4 (2,3,4,5) | 3.57 | 4.1 | Citrate | M |
3 | 17.9 | 2 | 1 (3) | 2.30 | 1.1 | Citrate | M |
4 | 21.6 | 0 | 1 (1) | 3.17 | 0.8 | Citrate | M |
5 | 24.2 | 8 | 1 (9) | 3.85 | 0.9 | Heparin | M |
6 | 15.1 | 7 | 3 (9,10,12) | 2.07 | 1.5 | Heparin | M |
7 | 26.3 | 0 | 3 (1,3,6) | 4.41 | 1.8 | None | M |
8 | 26.0 | 2 | 1 (3) | 3.20 | 0.5 | None | M |
9 | 22.0 | 2 | 3 (3,4,5) | 2.60 | 1.9 | Citrate | M |
10 | 22.0 | 1 | 3 (2,3,4) | 3.30 | 3.3 | Heparin | M |
11 | 29.3 | 25 | 2 (25,26) | 4.26 | 0.4 | None | M |
12 | 30.7 | 14 | 3 (14–16) | 5.66 | 1.6 | Heparin | M |
13 | 22.9 | 11 | 2 (11,13) | 3.77 | 1.3 | Heparin | M |
14 | 18.8 | 16 | 1 (16) | 3.07 | 0.8 | Heparin | M |
15 | 21.4 | 0 | 1 (1) | 2.60 | 1.4 | None | M |
16 | 20.0 | 2 | 2 (2,3) | 2.15 | 2.8 | Heparin | M |
17 | 22.5 | 1 | 2 (2,3) | 3.05 | 1.6 | Citrate | M |
18 | 24.2 | 0 | 3 (1,3,4) | 3.87 | 2.6 | Citrate | M |
19 | 31.2 | 1 | 1 (2) | 4.38 | 0.6 | None | M |
20 | 23.7 | 0 | 2 (1,2) | 2.83 | 1.8 | Heparin | M |
21 | 24.9 | 1 | 1 (2) | 3.47 | 0.9 | Citrate | C |
22 | 24.2 | 0 | 1 (1) | 3.77 | 0.8 | Citrate | M |
23 | 24.2 | 1 | 1 (2) | 4.20 | 0.9 | Citrate | C |